source
- GSK signs new agreement with China's Chimagen for trispecific T-cell engager targeting blood cancersGSK, the UK‑based pharmaceutical company, has entered into a fresh licensing agreement with Chinese biotech Chimagen Biosciences. The partnership focuses on a trispecific T‑cell engager designed fo…
- Experts urge FDA to require credentials for psychedelic therapy providersAt a recent public hearing, mental health experts called on the FDA to adopt safety measures as it pushes to speed up psychedelic therapy development. The experts specifically recommended that pro…